RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1
- PMID: 12738763
- DOI: 10.1210/me.2002-0402
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1
Abstract
Thyroid cancers are a leading cause of death due to endocrine malignancies. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) gene rearrangements are the most frequent genetic alterations identified in papillary thyroid carcinoma. Although the oncogenic potential of RET/PTC is related to intrinsic tyrosine kinase activity, the substrates for this enzyme are yet to be identified. In this report, we show that phosphoinositide-dependent kinase 1 (PDK1), a pivotal serine/threonine kinase in growth factor-signaling pathways, is a _target of RET/PTC. RET/PTC and PDK1 colocalize in the cytoplasm. RET/PTC phosphorylates a specific tyrosine (Y9) residue located in the N-terminal region of PDK1. Y9 phosphorylation of PDK1 by RET/PTC requires an intact catalytic kinase domain. The short (iso 9) and long forms (iso 51) of the RET/PTC kinases (RET/PTC1 and RET/PTC3) induce Y9 phosphorylation of PDK1. Moreover, Y9 phosphorylation of PDK1 by RET/PTC does not require phosphatidylinositol 3-kinase or Src activity. RET/PTC-induced phosphorylation of the Y9 residue results in increased PDK1 activity, decrease of cellular p53 levels, and repression of p53-dependent transactivation. In conclusion, RET/PTC-induced tyrosine phosphorylation of PDK1 may be one of the mechanisms by which it acts as an oncogenic tyrosine kinase in thyroid carcinogenesis.
Similar articles
-
Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.Mol Endocrinol. 2004 Nov;18(11):2672-84. doi: 10.1210/me.2004-0168. Epub 2004 Aug 5. Mol Endocrinol. 2004. PMID: 15297606
-
Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.Mol Endocrinol. 2003 Jun;17(6):1155-66. doi: 10.1210/me.2002-0401. Epub 2003 Mar 13. Mol Endocrinol. 2003. PMID: 12637586
-
[Effect of papillary thyroid carcinoma related gene PTC1 on subcellular localization and function of ATM cell].Ai Zheng. 2004 May;23(5):487-92. Ai Zheng. 2004. PMID: 15142440 Chinese.
-
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073. Cancer. 2005. PMID: 15880523 Review.
-
RET oncogene activation in papillary thyroid carcinoma.Adv Anat Pathol. 2001 Nov;8(6):345-54. doi: 10.1097/00125480-200111000-00005. Adv Anat Pathol. 2001. PMID: 11707626 Review.
Cited by
-
PDK1 protein phosphorylation at Thr354 by murine protein serine-threonine kinase 38 contributes to negative regulation of PDK1 protein activity.J Biol Chem. 2012 Jun 15;287(25):20811-22. doi: 10.1074/jbc.M111.331827. Epub 2012 Apr 27. J Biol Chem. 2012. PMID: 22544756 Free PMC article.
-
The major _target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway.Mol Biol Cell. 2005 Jan;16(1):348-57. doi: 10.1091/mbc.e04-05-0369. Epub 2004 Nov 10. Mol Biol Cell. 2005. PMID: 15537704 Free PMC article.
-
Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer.Endocrinol Metab (Seoul). 2022 Feb;37(1):53-61. doi: 10.3803/EnM.2022.1402. Epub 2022 Feb 28. Endocrinol Metab (Seoul). 2022. PMID: 35255601 Free PMC article.
-
Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia.Endocrinol Metab Clin North Am. 2008 Jun;37(2):375-87, viii-ix. doi: 10.1016/j.ecl.2008.01.001. Endocrinol Metab Clin North Am. 2008. PMID: 18502332 Free PMC article. Review.
-
Emerging Role of Oxidative Stress on EGFR and OGG1-BER Cross-Regulation: Implications in Thyroid Physiopathology.Cells. 2022 Feb 26;11(5):822. doi: 10.3390/cells11050822. Cells. 2022. PMID: 35269445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous